(12) United States Patent (10) Patent No.: US 8,652,778 B2 Bowman Et Al

Total Page:16

File Type:pdf, Size:1020Kb

(12) United States Patent (10) Patent No.: US 8,652,778 B2 Bowman Et Al US008652778B2 (12) United States Patent (10) Patent No.: US 8,652,778 B2 BOWman et al. (45) Date of Patent: *Feb. 18, 2014 (54) USE OF PHOTOPOLYMERIZATION FOR 5.449,602 A 9, 1995 Royer et al. AMPLIFICATION AND DETECTION OFA 5: A 3: Nilsen al MOLECULAR RECOGNITION EVENT 5,545,730I w A 8, 1996 UrdeaSee et al.all. 5,571,670 A 11/1996 Urdea et al. (75) Inventors: Christopher N. Bowman, Boulder, CO 5,573,907 A 11, 1996 A. al. (US); Kathy Rowlen, Boulder, CO (US); 5,580,731 A 12/1996 Chang et al. Hadley Sikes, Pasadena, CA (US); Ryan 3. A 3. s al Hansen, Golden, CO (US); Heather 5,594,118.-- I A 1/1997 UrdeaOCa, etCa. al. Jean Avens, Lafayette, CO (US) 5,597,909 A 1/1997 Urdea et al. 5,624,802 A 4/1997 Urdea et al. (73) Assignee: The Regents of the University of 5,635,352 A 6/1997 Urdea et al. Colorado, A Body Corporate, Denver, 5,637.460 A 6/1997 Swan et al. DE (US) 5,660,988 A 8/1997 Duck et al. 5,681,697 A 10, 1997 Urdea et al. 5,681,702 A 10, 1997 Collins et al. (*) Notice: Subject to any disclaimer, the term of this 5,710,264 A 1, 1998 E. al. patent is extended or adjusted under 35 5,770,722 A 6/1998 Lockhart et al. U.S.C. 154(b) by 0 days. 6,096,369 A 8, 2000 Anders et al. - - - - - 6,361,944 B1 3/2002 Mirkin et al. inplent is Subject to a terminal dis- (Continued) (21) Appl. No.: 13/082,814 FOREIGN PATENT DOCUMENTS y x- - - 9 EP O 383 126 8, 1990 (22) Filed: Apr. 8, 2011 WO WOOOf 43539 T 2000 O O Continued) (65)65 PriorO PublicationDO Dat OTHER( PUBLICATIONS US 2011 FO25.1092A1 Oct. 13, 2011 Tan et al. Bionanotechnology Based on Silica Nanoparticles. 2004. Medicinal Research Reviews, vol. 24, No. 5, pp. 621-638.* Related U.S. Application Data Taton et al. Scanometric DNA Array Detection with Nanoparticle (63) Continuation of application No. 12/099.560, filed on Probes. Sep 8, 2000. Science. vol. 289, p. 1757-1760.* Apr. 8, 2008, now abandoned, which is a Andras et al. (2001) "Strategies for Signal Amplification in Nucleic - - - - s Acid Detection.” Mol. Biotechnol. 19:29-44. continuation-in-part of application No. 11/372.485, Anthony et al. (2000) “Rapid Diagnosis of Bacteria by Universal filed on Mar. 9, 2006, now Pat. No. 7.354,706, which is Amplification of 23S Ribosomal DNA Followed by Hybridization to a continuation-in-part of application No. an Oligonucleotide Array.” J. Clin. Microbiol. 38:781-788. PCT/US2004/029733, filed on Sep. 9, 2004. Avens et al. (Sep. 2008) “Polymerization Behavior and Polymer Properties of Eosin-Mediated Surface Modification Reactions.” (60) Provisional application No. 60/988,563, filed on Nov. Polymer 49:4762-4768. 16, 2007, provisional application No. 60/982,992, Avens et al. (2009) “Mechanism of Cyclic Dye Regeneration During filed on Oct. 26, 2007, provisional application No. Eosin-Sensitivity Photoinitiation in the Presence of Polymerization 60/662,313, filed on Mar. 16, 2005, provisional Inhibitors. J. Polym. Sci. Polym. Chen. 47:6083-6094. application No. 60/501,755, filed on Sep. 9, 2003. (Continued) (51) Int. Cl. Primary Examiner — Anne Gussow CI2O I/68 (2006.01) Assistant Examiner — Channing S Mahatan C4OB 30/04 (2006.01) (74) Attorney, Agent, or Firm — Lathrop & Gage LLP: B82/30/00 (2011.01) Tamala R. Jonas; Sally Sullivan (52) U.S. Cl. (57) ABSTRACT USPC ................................. 435/6.1: 506/9; 977/773 The invention provides methods to detect molecular recogni (58) Field of Classification Search tion events. The invention also provides methods to detect the None presence of or identify a target species based on its interaction S ee appl1cauonlication fileIlle fIor completelet searcnh historv.n1Story withare based one or on more amplification probespecies. of the The signal methods due to ofeach the molecular invention (56) References Cited recognition event. The amplification is achieved through pho topolymerization, with the polymer formed being associated with the molecular recognition event. In one aspect, a fluo U.S. PATENT DOCUMENTS rescent polymer, a magnetic polymer, a radioactive polymer 4,749,647 A * 6/1988 Thomas et al. ................... 435/5 or an electrically conducting polymer can form the basis of 4,876, 187 A 10, 1989 Ducket al. detection and amplification. In another aspect, a polymer gel 5,011,769 A 4, 1991 Ducket al. Swollen with a fluorescent Solution, a magnetic solution, a 5,019,496 A 5, 1991 Oster et al. radioactive Solution oran electrically conducting Solution can 5,124,246 A 6, 1992 Urdea et al. form the basis of detection and amplification. In another 5,175.270 A 12/1992 Nilsen et al. aspect, detectable particles can be included in the polymer 5,185,243 A 2f1993 Ullman et al. formed. In another aspect, sufficient polymer forms to be 5,196,306 A 3, 1993 Bobrow et al. 5,359,100 A 10, 1994 Urdea et al. detectable by visual inspection. 5,403,711 A 4/1995 Walder et al. 34 Claims, 16 Drawing Sheets US 8,652.778 B2 Page 2 (56) References Cited Collins et al. (1997) 'A Branched DNA Signal Amplification Assay for Quantification of Nucleic Acid Targets Below 100 Molecules/ U.S. PATENT DOCUMENTS ml.” Nuc. Acids Res. 25(15):2979-2984. Cruise et al. (Mar. 20, 1998) “A Sensitivity Study of the Key Param 6,372,937 B1 4/2002 Bobrow et al. eters in the Interfacial Photopolymerization of Poly(ethylene glycol) 6,406,845 B1* 6/2002 Walt et al. .................... 435/6.11 Diacrylate Upon Porcine Islets.” Biotechnol. Bioeng. 57(6):655-665. 6,417.340 B1 7/2002 Mirkin et al. Csako et al. (Web Release Aug. 2005) “Present and Future of Rapid 6,485,703 B1 1 1/2002 Cote et al. 6,495,324 B1 12/2002 Mirkin et al. and/or High-Throughput Methods for Nucleic Acid Testing.” Clinica 6,506,564 B1 1/2003 Mirkin et al. Chimica Acta 363:6-31. 6,582,921 B2 6, 2003 Mirkin et al. Daubendieketal. (1997)"Generation of Catalytic RNA's by Rolling 6,593,100 B2 7/2003 Bobrow et al. Transcription of Synthetic DNA Nanocircles.” Nat. Biotech. 15:273 6,602,669 B2 8/2003 Letsinger et al. 277. 6,610,491 B2 8, 2003 Mirkin et al. Ding etal. (Jan. 2004) “Quantitative Analysis of Nucleic Acids. The 6,645,721 B2 11/2003 Mirkin et al. Last Few Years of Progress,” J. Biochem. Mol. Biol. 37(1): 1-10. 6,667,122 B2 12/2003 Kaufmann Do et al. (Feb. 2007) “cDNA Labeling Strategies for Microarrays 6,673,548 B2 1/2004 Mirkin et al. Using Fluorescent Dyes.” Eng. Life Sci. 7(1):26-34. 6,682,895 B2 1/2004 Mirkin et al. Elghanian et al. (Aug. 22, 1997)"Selective Colorimetric Detection of 6,709,825 B2 3, 2004 Mirkin et al. Polynucleotides Based on the Distance—Dependent Optical Proper 6,720,147 B2 4/2004 Mirkin et al. 6,720,411 B2 4/2004 Mirkin et al. ties of Gold Nanoparticles.” Science 277: 1078-1081. 6,730.269 B2 5, 2004 Mirkin et al. Englisch et al. (Jun. 1991) “Chemically Modified Oligonucleotides 6,740,491 B2 5, 2004 Mirkin et al. as Probes and Inhibitors.” Angew. Chem. Int. Ed, Eng. 30(6):613-629. 6,750,016 B2 6, 2004 Mirkin et al. Epstein et al. (2002) “Fluorescence-Based Nucleic Acid Detection 6,759,199 B2 7/2004 Mirkin et al. and Microarrays.” Anaytica. Chimica Acta 469:3-36. 6,767,702 B2 7/2004 Mirkin et al. Gaylord etal. (Aug. 20, 2002) “DNA Detection Using Water-Soluble 6,773,884 B2 8, 2004 Mirkin et al. Conjugated Polymers and Peptide Nucleic Acid Probes.” Proc. Nat. 6,777, 186 B2 8, 2004 Mirkin et al. Acad. Sci. USA99(17): 10954-10957. 6,806,047 B2 10/2004 Goldberg et al. Hansen etal. (Jul. 2008)"Quantitative Evaluation of Oligonucleotide 7.354,706 B2 * 4/2008 Rowlen et al. .................... 435.5 Surface Concentrations Using Polymerization-Based Amplifica 2002/0001853 A1 1/2002 Obremski et al. 2002, 0071943 A1 6, 2002 Hawker et al. tion.” Anal. Bioanal. Chem. 392: 167-175. 2003/0236425 A1 12, 2003 Herr et al. Hansen et al. (2009) “Visual, Base-Specific Detection of Nucleic 2004, OO63146 A1 4/2004 Sayre et al. Acid Hybridization Using Polymerization-Based Amplification.” 2006/0286570 A1 12/2006 Rowlen et al. Anal. Biochen. 386:285-287. 2009,0005263 A1 1/2009 Kuck Hansen et al. (Dec. 1, 2007) “Visual Detection of Labeled 2009.0137405 A1 5/2009 Bowman et al. Oligonucleotides Using Visible Light-Polymerization-Based Ampli 2009/O163375 A1 6, 2009 Bowman et al. fication. Biomacromolecules, DOI 10.1021/bm7006727. 2012, 0071338 A1 3/2012 Bowman et al. Hardiman, G. (2004) “Microarray Platforms-Comparisons and Con trasts.” Pharmacogenomics 5:487-502. FOREIGN PATENT DOCUMENTS Hoheisel et al. (Mar. 2006) “Microarray Technology: Beyond Tran scription Profiling and Genotype Analysis.” Nat. Rev. Genet. 7:200 WO WO 2004/093845 11, 2004 210. WO WO 2005/024386 3, 2005 Husemann et al. (1999)"Surface Initiated Polymerization for Ampli WO WO 2006/031248 3, 2006 fication of Self-Assembled Monolayers Patterned by Microcontact WO WO 2007/095464 8, 2007 Printing.” Angew: Chem. Int. Ed. 38(5):647-649. International Search Report Corresponding to International Applica OTHER PUBLICATIONS tion No. PCT/US04/029733, Mailed Mar.
Recommended publications
  • Open Research Online Oro.Open.Ac.Uk
    Open Research Online The Open University’s repository of research publications and other research outputs The Role of Viral Load in the Pathogenesis of HIV-2 Infection in West Africa Thesis How to cite: Ariyoshi, Koya (1998). The Role of Viral Load in the Pathogenesis of HIV-2 Infection in West Africa. PhD thesis The Open University. For guidance on citations see FAQs. c 1998 Koya Ariyoshi https://creativecommons.org/licenses/by-nc-nd/4.0/ Version: Version of Record Link(s) to article on publisher’s website: http://dx.doi.org/doi:10.21954/ou.ro.000101f4 Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies page. oro.open.ac.uk THE ROLE OF VIRAL LOAD D< THE PATHOGENESIS OF HTV-2 INFECTION IN WEST AFRICA BY KOYAARIYOSHI MRC Laboratories, Fajara, The Gambia, West Africa ^ ew • I A thesis submitted to the Open University in fulfilment for the degree of Doctor of Philosophy 1998 Collaborating Establishments: University College Medical School (London) Statens Serum Institute (Copenhagen) Institute of Molecular Medicine (Oxford) Institute of Cancer Research (London) _ ProQuest Number:C706741 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion.
    [Show full text]
  • New and Emerging Yeast Pathogens KEVIN C
    CLINICAL MICROBIOLOGY REVIEWS, Oct. 1995, p. 462–478 Vol. 8, No. 4 0893-8512/95/$04.0010 Copyright q 1995, American Society for Microbiology New and Emerging Yeast Pathogens KEVIN C. HAZEN* Division of Clinical Microbiology, Department of Pathology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908 INTRODUCTION .......................................................................................................................................................462 DEFINITION OF NEW OR EMERGING YEAST PATHOGENS ......................................................................462 WHICH YEASTS ARE NEW OR EMERGING PATHOGENS? .........................................................................463 ANATOMIC SITES ATTACKED BY YEASTS.......................................................................................................464 HISTOPATHOLOGY .................................................................................................................................................466 TREATMENT OF INFECTIONS DUE TO UNUSUAL YEASTS .......................................................................466 Catheter Removal ...................................................................................................................................................466 Antifungal Therapy.................................................................................................................................................469 MICROBIOLOGICAL IDENTIFICATION ............................................................................................................469
    [Show full text]
  • Helicobacter Pylori
    Advanced Techniques in Diagnostic Microbiology Yi-Wei Tang Charles W. Stratton Advanced Techniques in Diagnostic Microbiology Yi-Wei Tang Charles W. Stratton Molecular Infectious Disease Laboratory Clinical Microbiology Laboratory Vanderbilt University Medical Center Vanderbilt University Medical Center Nashville, TN 37232-5310 Nashville, TN 37232-5310 USA USA [email protected] [email protected] Library of Congress Control Number: 2005935335 ISBN-10: 0-387-29741-3 e-ISBN 0-387-32892-0 ISBN-13: 978-0387-29741-5 Printed on acid-free paper. C 2006 Springer Science+Business Media, LLC. All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Printed in the United States of America. (TB/EB) 987654321 springer.com Contributors Jaber Aslanzadeh Ali Danesh Division of Clinical Department of Experimental Microbiology Therapeutics Department of Pathology University Health Network Hartford Hospital and Clinical 200 Elizabeth Street Laboratory Partners Toronto, Ontario, Canada M5G 2C4 85 Seymour Street Hartford, CT 06102, USA Diane Dare Research Development Unit George Bolton Manchester Metropolitan BD Biosciences University 10975 Torreyana Road St.
    [Show full text]
  • Pharmacoeconomics
    PharmacoEconomics The costs of diagnosing and treating sexually transmitted infections in low- and middle- income countries from 2006 to 2014: An updated systematic review --Manuscript Draft-- Manuscript Number: Full Title: The costs of diagnosing and treating sexually transmitted infections in low- and middle- income countries from 2006 to 2014: An updated systematic review Article Type: Systematic Review Funding Information: United States Agency for International Not applicable Development (AID-674-A-12-00029) Abstract: Background: Sexually transmitted infections (STIs) are co-factors for HIV infection and can cause significant morbidity. Expanding on a prior systematic review, we aimed to summarize recent literature on the costs of diagnosing and treating curable STIs in low- and middle-income countries (LMICs). Methods: We conducted a systematic review using pre-established search strategies. Citations were eligible if published between 1 January 2006 and 31 December 2014 and if they contained provider-perspective cost information reflective of STI-related service provision in LMICs. We extracted all cost values and used regression analysis to explore determinants. Cost drivers were analyzed thematically. Results: We identified 44 articles for inclusion; 24 (54.6%) represented Sub-Saharan Africa. We extracted 202 cost values; 72 (35.6%) characterized syndromic management approaches, 57 (28.2%) mobile outreach services. Syphilis was a common focus (70 (34.7%)). Sixty-five (32.2%) cost values represented cost- effectiveness measures as compared to simple unit costs. The median for all cost values was (USD 2015) $10.90 (cost-effectiveness measures $115.88; unit costs $4.15). Regression analysis indicated that cost effective measures were lower in Africa than other continents.
    [Show full text]
  • Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications
    CLINICAL MICROBIOLOGY REVIEWS, July 1998, p. 533–554 Vol. 11, No. 3 0893-8512/98/$04.0010 Copyright © 1998, American Society for Microbiology. All Rights Reserved. Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications 1 2 MICHAEL BOECKH * AND GUY BOIVIN Fred Hutchinson Cancer Research Center, Seattle, Washington,1 and Centre Hospitalier de l’Universite´ Laval, Sainte-Foy, Quebec, Canada2 INTRODUCTION .......................................................................................................................................................534 PATHOPHYSIOLOGY OF CMV DISSEMINATION ...........................................................................................534 METHODS FOR CMV QUANTIFICATION..........................................................................................................534 Quantitative Viral Cultures...................................................................................................................................535 Principle and assay characteristics..................................................................................................................535 Assay performance..............................................................................................................................................535 Reproducibility and test accuracy ....................................................................................................................535 Summary ..............................................................................................................................................................535
    [Show full text]
  • Duke University Dissertation Template
    On-chip Labeling via Surface Initiated Enzymatic Polymerization (SIEP) for Nucleic Acids Hybridization Detection by Vinalia Tjong Department of Biomedical Engineering Duke University Date:_______________________ Approved: ___________________________ Ashutosh Chilkoti, Supervisor ___________________________ Stefan Zauscher ___________________________ William Reichert ___________________________ Gabriel Lopez ___________________________ Aimee Zaas Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biomedical Engineering in the Graduate School of Duke University 2013 i v ABSTRACT On-chip Labeling via Surface Initiated Enzymatic Polymerization (SIEP) for Nucleic Acids Hybridization Detection by Vinalia Tjong Department of Biomedical Engineering Duke University Date:_______________________ Approved: ___________________________ Ashutosh Chilkoti, Supervisor ___________________________ Stefan Zauscher ___________________________ William Reichert ___________________________ Gabriel Lopez ___________________________ Aimee Zaas An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biomedical Engineering in the Graduate School of Duke University 2013 i v Copyright by Vinalia Tjong 2013 Abstract Current techniques for nucleic acid analysis often involve extensive sample preparation that requires skilled personnel and multiple purification steps. In this dissertation, we introduce an on-chip,
    [Show full text]
  • Point-Of-Care Diagnostics for Lung Transplantation
    Point-of-Care Diagnostics for Lung Transplantation by Andrew Thomas Sage A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Graduate Department of Pharmaceutical Sciences University of Toronto © Copyright by Andrew Thomas Sage 2015 Point-of-Care Diagnostics for Lung Transplantation Andrew Thomas Sage Doctor of Philosophy Graduate Department of Pharmaceutical Sciences University of Toronto 2015 Abstract Over the last few decades, lung transplantation (LTx) has become a well-established therapy for patients suffering from end-stage lung disease. Despite the many innovations that have occurred in recent years, the outcomes following LTx still lag behind those of other organ transplant procedures due to a lack of technologies that could monitor predictive biomarkers. Recently, several genomic and proteomic analytes have been identified that are prognostic of LTx outcome; however, traditional analytical methods are impractical for use in the transplant setting. Rapid analysis of molecular biomarkers reporting on the initial and long-term status of a donated organ would improve utilization rates and transplant outcomes. The work herein focuses on developing a novel class of chip-based sensors that would enable direct analysis of mRNAs and proteins that are correlated with the suitability of a lung for transplant. The biosensing approach utilized in these studies was performed using a simple and elegant electrochemical reporter system with metal electrodes of varying morphologies and sizes. ii By fabricating fractal circuit sensors (FraCS), we demonstrated the technological and biological validation required for a point-of-care (POC) diagnostic device to be used for gene quantitation in the transplant setting.
    [Show full text]
  • Attachment 1 Statewide Standard List of Abbreviations
    Statewide Standard List of Abbreviations Revised June 28, 2016 Attachment 1 Statewide Standard List of Abbreviations Table of Contents Table 1: Abbreviations, Acronyms and Symbols ............................................................. 2 Table 2: Do NOT Use Abbreviations ............................................................................. 25 1 Statewide Standard List of Abbreviations Revised June 28, 2016 Table 1: Abbreviations, Acronyms and Symbols Abbreviation or Acronym Definition (L) left (R) right /hpf per high power field ā before A and O alert and oriented A and P auscultation and percussion aa of each AACRN Advanced AIDS Certified Registered Nurse AAHIVM American Academy of HIV medicine AB abortion abd abdomen ac before meals ACHES Abdominal pain, chest pain, headache, eye problems, and severe leg pains (early danger signs of oral contraceptive adverse effects) ACRN AIDS Certified Registered Nurse ACTG AIDS Clinical Trial Group ADA American Dietetic Association ADAP AIDS Drug Assistance Program ADC AIDS Dementia Complex ADLs Activities of daily living AED automated external defibrillator AETC AIDS Education and Training Centers AF anteflexed AFB acid-fast bacilli AGCUS atypical glandular cells of undetermined significance AGN Acute glomerulonephritis AHYD Adolescent Health and Youth Development AIDS acquired immunodeficiency syndrome AIN anal intraepithelial neoplasia AlkPhos alkaline phosphatase ALT alanine aminotransferase 2 Statewide Standard List of Abbreviations Revised June 28, 2016 amb ambulatory AMBU air-shields
    [Show full text]
  • Branched Dna Nanostructures for Molecular Diagnostics
    BRANCHED DNA NANOSTRUCTURES FOR MOLECULAR DIAGNOSTICS A Dissertation Presented to the Faculty of the Graduate School of Cornell University in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Mark Richard Hartman August 2013 © 2013 Mark Richard Hartman ALL RIGHTS RESERVED ii BRANCHED DNA NANOSTRUCTURES FOR MOLECULAR DIAGNOSTICS Mark Richard Hartman, Ph.D. Cornell University 2013 DNA nanotechnology has been enormously successful in using DNA as a nanoscale construction material, and consistent progress in using increasingly complex DNA- mediated assemblies and designs has been reported in the literature. However, the field of DNA nanostructures has sometimes been lacking for concrete applications. Meanwhile, DNA has also been widely used as probes and primers for nucleic acid diagnostics applications, and this provides an extremely critical application with potential for great medical benefits, and these DNA probes and primers are readily interfaced with DNA nanotechnology. Thus, in this Dissertation, I discuss the combination of (1) DNA in its role as a recognition element for nucleic acid detection, and (2) DNA as a structural material for nanoscale self-assembly. This combination represents a fusion of “structure” and “function”, and will ultimately lead to great advancements in the field of nucleic acid diagnostics. iii BIOGRAPHICAL SKETCH I received my B.S. degree in Chemical and Biomolecular Engineering from Cornell University in 2007. As an undergraduate with a minor in Biological Engineering, I worked with Prof. Dan Luo in the Biological and Environmental Engineering on the design and synthesis of DNA nanostructures and portable detection using DNA nanobarcodes. Upon graduation, I remained at Cornell and entered the Masters of Engineering program (2007 – 2008), where I worked on DNA-mediated self-assembly of gold nanoparticles.
    [Show full text]
  • Lennette's Laboratory Diagnosis of Viral
    Lennette’s Laboratory Diagnosis of Viral Infections NFECT I OUS I SEASE Fourth Edition Fourth I D Edition AN D THERAPY SER I ES About the book Volume 50 • Written from the perspective of the diagnostician, this bestselling book is the definitive text on the laboratory diagnosis of human viral diseases. • Contains a wealth of illustrations, tables, and algorithms to enhance your understanding of Viral Infections Viral of Lennette’s Lennette’s of this ever-evolving field. • A ready reference source for virologists, microbiologists, epidemiologists, laboratorians, infectious disease specialists and students. Laboratory Unique features • Has a new syndromic approach and discusses the differential diagnosis of potential causative agents along with suggestions for the appropriate diagnostic response. Diagnosis of • Examines the field’s rapid changes in technology, the continuing emergence of new viruses, and the newly described viral etiologies for clinical syndromes. Laboratory Diagnosis • Explores the increasingly important subject of molecular techniques in detail, covering the design of molecular tests, the importance of genotyping and viral Viral Infections sequence analysis, and the use of microarrays in diagnostic virology. Reviews of previous editions Fourth Edition a worthy addition to the bookshelves of the specialised virus laboratory as it contains a wealth of information not readily available elsewhere. The Journal of Clinical Pathology a comprehensive and valuable addition to any medical library. It will appeal to all students of virology, medical microbiology and infectious diseases. The information is set out in a user-friendly fashion and allows the reader to obtain pertinent information without being deluged with too many data [...] recommend[ed] highly.
    [Show full text]
  • Etude De Determinants De La Transmission Du Vih De La Mere a L’Enfant Au Burkina Faso
    UNIVERSITE LIBRE DE BRUXELLES ANNEE 2003-2004 THESE Pour obtenir le grade académique de DOCTEUR EN SCIENCES AGRONOMIQUES ET INGENIERIE BIOLOGIQUE FACULTE DES SCIENCES Par Mr Olivier MANIGART ETUDE DE DETERMINANTS DE LA TRANSMISSION DU VIH DE LA MERE A L’ENFANT AU BURKINA FASO Jury : Directeur de thèse : Mr le Professeur Philippe VAN DE PERRE, co- Directrice de thèse : Mme le Professeur Carine VAN LINT, Président : Mr le Professeur Georges HUEZ, Mme le Professeur Véronique HALLOIN, Mr le Professeur Nicolas MEDA, Mr le Professeur John WERENNE, Mr le Professeur Arsène BURNY, Mr le Professeur Philippe LEPAGE. 1 Couverture : route Ouagadougou – Bobo-Dioulasso, juillet 2003. 2 A ma petite fille adorée, Isia, 3 4 Je me suis réveillé, tiré de la lourde torpeur d’une sieste de saison sèche par des cris stridents et des acclamations saccadées qui provenaient du devant de ma cour. Je me suis levé lourdement et j’ai écarté le pagne qui protège de la lumière et de la chaleur tellement vives en cette période, pour découvrir que les « Masques » étaient descendus dans la rue. Au contraire, la lumière était diffuse et sinistre et la lourdeur de l’air était telle qu’une angoisse profonde m’étreignit instantanément. En général, les « Masques » sortent lors de périodes rituelles – ce qui n’était pas le cas – ou, au cours de phénomènes étranges. Ce sont les initiés qui portent le masque et qui fustigent à tout-vas : c’est souvent l’occasion de corrections exemplaires pour ceux qui se sont mal comportés… ou de vengeances personnelles. J’ai levé les yeux pour observer le ciel : il était obscurci d’un halo de nuages circulaire d’un diamètre de ce qui semblait être plusieurs kilomètres.
    [Show full text]
  • Mycology Proficiency Testing Program
    Mycology Proficiency Testing Program Test Event Critique May 2014 Table of Contents Mycology Laboratory 2 Mycology Proficiency Testing Program 3 Test Specimens & Grading Policy 5 Test Analyte Master Lists 7 Performance Summary 9 Commercial Device Usage Statistics 11 Yeast Descriptions 12 Y-1 Candida parapsilosis 12 Y-2 Candida glabrata 15 Y-3 Rhodotorula minuta 18 Y-4 Trichosporon asahii 21 Y-5 Prototheca wickerhamii 24 Antifungal Susceptibility Testing - Yeast 27 Antifungal Susceptibility Testing - Mold (Educational) 29 1 Mycology Laboratory Mycology Laboratory at the Wadsworth Center, New York State Department of Health (NYSDOH) is a reference diagnostic laboratory for the fungal diseases. The laboratory services include testing for the dimorphic pathogenic fungi, unusual molds and yeasts pathogens, antifungal susceptibility testing including tests with research protocols, molecular tests including rapid identification and strain typing, outbreak and pseudo-outbreak investigations, laboratory contamination and accident investigations and related environmental surveys. The Fungal Culture Collection of the Mycology Laboratory is an important resource for high quality cultures used in the proficiency-testing program and for the in-house development and standardization of new diagnostic tests. Mycology Proficiency Testing Program provides technical expertise to NYSDOH Clinical Laboratory Evaluation Program (CLEP). The program is responsible for conducting the Clinical Laboratory Improvement Amendments (CLIA)-compliant Proficiency Testing (Mycology) for clinical laboratories in New York State. All analytes for these test events are prepared and standardized internally. The program also provides continuing educational activities in the form of detailed critiques of test events, workshops and occasional one-on-one training of laboratory professionals. Mycology Laboratory Staff and Contact Details Name Responsibility Phone Email Director (on leave of Dr.
    [Show full text]